The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2015
Filed:
Dec. 17, 2014
Applicant:
Vaxlnnate Corporation, Cranbury, NJ (US);
Inventors:
Langzhou Song, Cranbury, NJ (US);
Lynda G. Tussey, Cranbury, NJ (US);
Alan R. Shaw, Cranbury, NJ (US);
Robert S. Becker, Cranbury, NJ (US);
Yi Zhang, Cranbury, NJ (US);
Scott W. Umlauf, Cranbury, NJ (US);
Ge Liu, Cranbury, NJ (US);
Assignee:
VaxInnate Corporation, Cranbury, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/112 (2006.01); A61K 39/295 (2006.01); C07K 14/11 (2006.01); C07K 14/255 (2006.01); C07K 19/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); C07K 14/005 (2006.01); C07K 14/205 (2006.01); C07K 14/21 (2006.01); C07K 14/24 (2006.01); C07K 14/245 (2006.01); C07K 14/32 (2006.01); C12N 7/00 (2006.01); A61K 39/155 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0005 (2013.01); A61K 39/0275 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/155 (2013.01); A61K 39/295 (2013.01); A61K 39/39 (2013.01); C07K 14/005 (2013.01); C07K 14/11 (2013.01); C07K 14/205 (2013.01); C07K 14/21 (2013.01); C07K 14/24 (2013.01); C07K 14/245 (2013.01); C07K 14/255 (2013.01); C07K 14/32 (2013.01); C07K 19/00 (2013.01); C12N 7/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/55544 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6068 (2013.01); C07K 2319/40 (2013.01); C07K 2319/75 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16162 (2013.01); C12N 2760/16171 (2013.01); C12N 2760/16222 (2013.01); C12N 2760/16234 (2013.01); C12N 2760/18522 (2013.01); C12N 2760/18534 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01);
Abstract
Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.